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Does advancing male age 
influence the expression levels 
and localisation patterns of 
phospholipase C zeta (PLCζ) in 
human sperm?
Marc Yeste1,#, Celine Jones1, Siti Nornadhirah Amdani1,2, Suseela Yelumalai1,†, Ginny Mounce1, 
Sarah J. Martins da Silva3,4, Tim Child1,5 & Kevin Coward1
Socio-economic factors have led to an increasing trend for couples to delay parenthood. However, 
advancing age exerts detrimental effects upon gametes which can have serious consequences upon 
embryo viability. While such effects are well documented for the oocyte, relatively little is known with 
regard to the sperm. One fundamental role of sperm is to activate the oocyte at fertilisation, a process 
initiated by phospholipase C zeta (PLCζ), a sperm-specific protein. While PLCζ deficiency can lead to 
oocyte activation deficiency and infertility, it is currently unknown whether the expression or function 
of PLCζ is compromised by advancing male age. Here, we evaluate sperm motility and the proportion 
of sperm expressing PLCζ in 71 males (22–54 years; 44 fertile controls and 27 infertile patients), along 
with total levels and localisation patterns of PLCζ within the sperm head. Three different statistical 
approaches were deployed with male age considered both as a categorical and a continuous factor. 
While progressive motility was negatively correlated with male age, all three statistical models 
concurred that no PLCζ–related parameter was associated with male age, suggesting that advancing 
male age is unlikely to cause problems in terms of the sperm’s fundamental ability to activate an oocyte.
Infertility affects 1 in 7 couples and is defined as the inability of a couple to achieve pregnancy after one year of 
unprotected intercourse1. Considered as a disease by the World Health Organisation (WHO)2, infertility is known 
to arise from multi-factorial origins. Between 25 and 30% of cases relate to a male factor, while 20–35% relates to 
a female factor, and 25–40% arise from a combination of both male and female factors. Worryingly, 10–25% of 
cases remain idiopathic/unexplained (reviewed in ref. 3).
Male factor infertility is frequently associated with abnormal semen quality parameters such as low sperm 
concentration (oligozoospermia), poor motility (asthenozoospermia), abnormal morphology (teratozoospermia) 
or even the complete absence of sperm (azoospermia). Such problems can be attributed to spermatogenic defi-
ciencies and/or abnormal epididymal maturation, and may arise from either genetic or extrinsic factors4. In this 
context, advancing male age has been reported to be associated with a gradual decline in sperm quality, which 
may result in sub-fertility5,6. This reduction in sperm quality not only affects conventional parameters, such as 
semen volume and sperm motility7–9, but is also related to increased proportions of sperm with either fragmented 
DNA10–13, or chromosomal defects14,15.
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Upon ovulation, oocytes are held in metaphase-II arrest and can only complete meiosis-II when activated 
by the fertilizing sperm16. A mounting body of evidence from both basic and clinical research now provides 
clear support for phospholipase C zeta 1 (PLCζ ) as the sperm-borne protein factor responsible for activating 
the oocyte upon gamete fusion17–19. Following diffusion into the ooplasm, PLCζ triggers a series of intracellular 
calcium oscillations that subsequently drives a cascade of biological events, including cortical granule exocytosis, 
prevention of polyspermy, polar body extrusion, cytoskeletal rearrangements and the formation of pronuclei17–21.
Over recent years, a series of clinical studies have clearly related PLCζ deficiency to male infertility. For exam-
ple, abnormal expression levels or genetic mutations may lead to oocyte activation deficiency (OAD) and total 
fertilisation failure (TFF)22–27. Furthermore, the proportions of sperm exhibiting PLCζ in a semen sample are cor-
related with fertilisation outcome following intracytoplasmic injection (ICSI) but not following in vitro fertilisa-
tion (IVF)28. In addition, although seven different PLCζ -localisation patterns have been identified in human sperm 
(acrosomal; post-acrosomal; equatorial; acrosomal and post-acrosomal; acrosomal and equatorial; post-acrosomal 
and equatorial; acrosomal, post-acrosomal and equatorial)29, only the specific localisation of PLCζ in the equa-
torial and post-acrosomal regions are correlated with fertilisation rates following ICSI28. Moreover, while 
genetic causes, such as those underlying globozoospermia, may result in sperm which are devoid of PLCζ 25,26,30, 
the potential effects of other factors, including male age, have received far less attention31. Such considerations 
are becoming very relevant because, for various socio-economic factors, the age of fatherhood is progressively 
increasing. Indeed, the proportion of men aged 35–55 years of age and fathering a child has increased by 
approximately 15% over the last decade32.
Against this background, the present study sought to determine whether paternal age exerts impact upon 
the expression or localisation of PLCζ in human semen samples, and to determine whether the influence of age 
differs between fertile controls and infertile patients.
Results
Differences between age groups and between fertile controls and infertile patients in the pro-
portions, total levels and localisation patterns of PLCζ. When age was considered as a categorical 
factor, no significant (P > 0.05) differences were detected between the two age groups (i.e.  < 40 and ≥ 40) within 
either fertile control or infertile patient groups (Fig. 1). In contrast, the proportions (%) of sperm exhibiting PLCζ 
were significantly (P < 0.05) higher in controls than in patients, for both age groups. No interaction (P > 0.05) 
between the classification of samples (fertile controls or infertile patients) and age groups were observed and, 
thus, the effects of age on the proportions of sperm exhibiting PLCζ were similar in control and patient groups. 
Similar findings were observed for the total levels of PLCζ , in which fertile controls presented significantly 
(P = 0.01) higher levels of PLCζ than infertile patients, but without significant differences (P > 0.05) between the 
two age groups (Fig. 2).
The proportion (%) of sperm exhibiting PLCζ in acrosomal (A), post-acrosomal (PA), acrosomal + 
post-acrosomal (A + PA), acrosomal + equatorial (A + E), post-acrosomal + equatorial (PA + E) and acroso-
mal + post-acrosomal + equatorial (A + PA + E) localisation patterns did not differ significantly, either between 
fertile controls and infertile patients, or between the two age groups (Table 1). In contrast, the proportion (%) 
of sperm exhibiting PLCζ in the equatorial region only were significantly higher, and those devoid of PLCζ sig-
nificantly (P < 0.05) lower, in fertile controls than in infertile patients. In spite of such differences, there were no 
significant differences between the age groups tested.
Correlation of male age with proportions, total levels and localisation patterns of PLCζ. None 
of the parameters evaluated for PLCζ (proportions, total levels or localisation patterns), either in fertile controls 
Figure 1. Proportions of sperm exhibiting PLCζ (mean ± SEM) in fertile controls and infertile patients 
younger than 40 years of age, or equal to and older than 40 years of age. Different letters in superscript (a,b) 
denote significant (P < 0.05) differences between controls, patients and age groups. Fertile controls presented 
significantly higher proportions of sperm exhibiting PLCζ than infertile patients, but no significant differences 
were found in relation to male age.
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or infertile patients, was significantly correlated with male age (Table 2). The same result was obtained when sam-
ples from fertile controls and infertile patients were analysed collectively as one common group.
Clustering of data into fertile controls and infertile patients, and age groups. All parameters 
used to evaluate PLCζ (proportions, total levels, and localisation patterns) were also used for additional cluster 
analysis. The optimal number of clusters was two and the descriptive parameters used for these two clusters are 
shown in Table 3. When logistic regression models were used to evaluate the effects of age (considered as both 
continuous and categorical factors), it was apparent that male age (χ 2 Wald = 0.05; P > 0.05) did not determine 
the pertinence of cases to any specific cluster. In contrast, the male pertinence to either fertile control or infertile 
patient groups was included as a factor in the model (χ 2 Wald = 11.09; P < 0.05), which indicated that pertinence 
of a given case to a specific cluster relied on whether the case was a fertile control or an infertile patient.
Relationship between age and other sperm quality parameters. Male age was significantly 
(P < 0.05) associated with total sperm motile count and the proportion of sperm with progressive motility. This 
was not only observed when male age was considered as a categorical variable, but also when correlations were 
calculated with male age being considered as a continuous variable (Table 4). When correlations were calculated 
from individuals belonging to controls or patients groups, the age was correlated to motile count and progressive 
sperm motility.
Discussion
Although advancing parental age is recognised as a risk factor for sub-fertility, the age of fatherhood has been 
steadily increasing over the last few decades, particularly in Western countries32. Thus far, the bulk of research 
attention has focused upon the consequences of advancing maternal age and the potential implications for 
mother and child33,34. In comparison, far less focus has been directed towards the potential effect of paternal age5. 
Figure 2. Total levels of PLCζ per spermatozoon (fluorescence intensity, arbitrary units), as mean ± SEM, 
in fertile controls and infertile patients less than 40 years of age, or equal to and older than 40 years of age. 
Different letters in superscript (a,b) denote significant (P < 0.05) differences between controls, patients and age 
groups. Fertile controls presented significantly higher proportions of sperm exhibiting PLCζ than patients, but 
no significant differences were found in relation to male age.
PLCζ 
localisation
Fertile Controls (n = 44) Infertile Patients (n = 27)
<40 years ≥40 years <40 years ≥40 years
A 1.4 ± 0.5 1.2 ± 0.6 2.4 ± 1.2 2.6 ± 1.2
PA 8.1 ± 2.1 8.0 ± 2.3 6.2 ± 2.0 7.6 ± 2.5
E 31.5 ± 5.3a 23.3 ± 6.2a,b 14.5 ± 3.9b,c 10.1 ± 4.3c
A + PA 0.9 ± 0.2 0.8 ± 0.6 2.1 ± 0.9 3.5 ± 1.8
A+ E 4.7 ± 1.8 1.9 ± 0.7 0.9 ± 0.5 1.1 ± 0.5
PA+ E 22.2 ± 4.4 29.5 ± 7.4 24.1 ± 5.8 25.9 ± 9.8
A + PA + E 14.8 ± 3.1 19.3 ± 5.7 12.0 ± 4.5 12.4 ± 5.2
None 16.3 ± 2.8a 16.0 ± 5.5a 37.8 ± 7.7b 36.7 ± 10.8b
Table 1.  Proportions (%) of sperm exhibiting PLCζ (mean ± SEM) in fertile controls and infertile patients 
in two age groups. Different superscripts (a, b, c) denote significant differences between columns within a given 
row. [Specific localisation patterns of PLCζ are referred to as: A = acrosomal; E = equatorial; None = absence of 
PLCζ ; PA = post-acrosomal. ‘None’ refers to sperm that were completely devoid of PLCζ ].
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Within this limited body of research, previous work has established that advancing male age results in a steady 
reduction in sperm quality, increased proportions of sperm with fragmented DNA and an increased risk of infer-
tility6,9,10,13,35. However, it remains to be determined whether male age has any other effects upon relevant sperm 
proteins, such as PLCζ .
One fundamental role of the sperm is to activate the oocyte upon gamete fusion at fertilisation. This vital sig-
nalling mechanism is initiated and regulated by PLCζ , a sperm-specific protein, and a number of previous publi-
cations have associated PLCζ -deficiency with oocyte activation deficiency or total fertilisation failure22,23,25,26,28,36. 
While biochemical and clinical evidence continues to accrue with regard to the implicit association between PLCζ 
and successful oocyte activation3,17, very little is known as to how PLCζ -deficiency arises in the first place. The 
PLCζ 
localisation
Fertile Controls 
(n = 44)
Infertile Patients 
(n = 27)
Overall 
(n = 71)
% Sperm 
exhibiting PLCζ 0.02 0.05 0.01
Total levels of 
PLCζ 0.14 − 0.06 − 0.02
Localisation patterns (%)
 A 0.13 0.02 0.09
 PA 0.19 − 0.08 0.08
 E − 0.13 − 0.21 − 0.15
 A + PA 0.17 0.11 0.14
 A+ E − 0.04 0.01 − 0.04
 PA+ E 0.10 − 0.06 0.03
 A + PA + E 0.05 0.05 0.02
 None − 0.14 0.32 0.07
Table 2.  Correlation coefficients between age and different PLCζ patterns in fertile controls, in infertile 
patients, and without separating these two groups (overall). No significant correlations were observed in any 
of the cases evaluated. [Specific localisation patterns of PLCζ are referred to as: A = acrosomal; E = equatorial; 
None = absence of PLCζ ; PA = post-acrosomal. ‘None’ refers to sperm that were completely devoid of PLCζ ].
PLCζ Cluster 1 Cluster 2
N 47 24
% Sperm exhibiting PLCζ 88.9 ± 1.2 36.9 ± 5.5
Total levels of PLCζ 37.2 ± 2.3 22.6 ± 2.6
Localisation patterns (%)
 A 1.4 ± 0.4 2.4 ± 1.0
 PA 7.4 ± 1.4 7.9 ± 1.9
 E 29.3 ± 3.8 10.8 ± 2.9
 A + PA 1.4 ± 0.5 1.3 ± 0.6
 A+ E 3.5 ± 1.1 1.0 ± 0.4
 PA+ E 29.9 ± 3.9 8.5 ± 1.8
 A + PA + E 15.7 ± 2.6 10.6 ± 3.0
 None 11.3 ± 1.1 52.7 ± 5.8
Table 3.  Descriptive parameters (mean ± SEM) for the two clusters obtained following two-step cluster 
analysis using all sperm samples collectively. [Specific localisation patterns of PLCζ are referred to as: 
A = acrosomal; E = equatorial; None = absence of PLCζ ; PA = post-acrosomal. ‘None’ refers to sperm that were 
completely devoid of PLCζ ].
Parameter
Fertile Controls 
(n = 44)
Infertile Patients 
(n = 27)
Overall 
(n = 71)
% Progressive 
motile sperm − 0.31* − 0.29* − 0.34* 
Total sperm 
motile count − 0.28* − 0.27* − 0.30* 
Table 4.  Correlation coefficients between male age, % progressive motile sperm and total sperm motile 
count in fertile controls, infertile patients, and when both groups were analysed collectively (overall). 
Asterisk (* ) denotes significant correlation (P < 0.05).
www.nature.com/scientificreports/
5Scientific RepoRts | 6:27543 | DOI: 10.1038/srep27543
present study firstly confirmed that infertile patients presented lower proportions of sperm exhibiting PLCζ , as 
reported previously28,36, but secondly, failed to find any correlation between male age and any of the PLCζ -related 
parameters tested (i.e. total levels, localisation patterns, or the proportions of sperm exhibiting PLCζ ). We arrived 
at the same conclusion using three distinct and independent statistical approaches (ANOVA, correlation, cluster 
analysis and further logistic regression). In addition, the absence of age effects upon PLCζ -related parameters was 
not only observed when samples were separated as fertile controls and infertile patients, but also when these two 
groups were analysed collectively as one larger cohort.
Two of the three statistical approaches employed (ANOVA, and cluster analysis followed by logistic regres-
sion) considered male age as a categorical factor. The cut-off value for classifying patients into two different age 
groups was assigned to 40 years of age, concurring with previous studies that reported an apparent reduction in 
sperm quality upon reaching this particular chronological milestone37,38. In addition, considering male age as a 
categorical or as a continuous factor yielded the same results, thus providing further justification to support our 
cut-off age value. Finally, clustering the samples according to proportions, total levels and PLCζ -localisation pat-
terns was not dependent on male age, either in fertile controls or in infertile patients.
In contrast to PLCζ -related parameters, male age was negatively correlated with motile sperm count and the 
proportion of sperm exhibiting progressive motility. These results are in agreement with earlier studies investi-
gating the effects of age upon sperm37,39. The fact that none of the three statistical approaches adopted to examine 
the effects of age upon PLCζ allowed us to distinguish between fertile controls and infertile patients not only 
made our current study comparable with previous reports, but also allowed us to exclude any interaction between 
male age and fertility status. In this regard, it is worth mentioning that Plastira et al.10 reported that while male 
age was negatively associated with sperm motility, morphology and DNA integrity in an infertile patient group, 
such age-effects were not evident in a fertile control group. In contrast to this study, the present work found a clear 
reduction of sperm motility with advancing age in both control and patient groups.
As mentioned earlier, increasing male age is related to reductions in semen volume, sperm motility and nor-
mal morphology, along with an increased likelihood of sperm DNA fragmentation6–11,13. It has been suggested 
that such reductions in sperm quality could arise from deterioration of the testicular tissue architecture which 
involves thickening of the basal membrane in seminiferous tubuli, reduction of the seminiferous epithelium and 
in the number of both Sertoli and Leydig cells, along with compromised testicular vascularisation40. An addi-
tional explanation could be related to changes in composition of seminal plasma occurring with advanced age41.
Although the precise mechanisms underlying the observed differences between fertile controls and infertile 
patients in terms of the proportion, total levels, and localisation pattern of PLCζ found here, and in previous 
studies28,36, are not yet fully understood, previous research has identified that genetic factors can underlie PLCζ 
deficiency, at least in some patients. For example, globozoospermia, an extreme case of teratozoospermia in 
which sperm can be totally devoid of PLCζ 25,30,42, is known to have a genetic cause43. In addition, two point muta-
tions in the coding region of the PLCζ gene have been found in a non-globozoospermic, infertile patient. These 
mutations affected the X and Y domains of PLCζ (substitution of histidine for leucine at residue 233 [H233L], and 
substitution of histidine for proline at residue 398 [H398P]), and were directly responsible for oocyte activation 
failure23,25,26. In the present work, we have shown that proportions, localisation patterns and total PLCζ levels 
are independent from male age. Since genetic factors have only been related to a very small number of patients 
thus far, more research is warranted to address which other factors might underlie the differences between fertile 
controls and infertile patients observed here and in other previous studies27,28,36.
The effect of paternal age on fertility outcome is far less consistent than those related to sperm quality. Indeed, 
while some studies indicate a positive correlation between age and infertility risk in men9,35, it is prudent to con-
sider that other factors could potentially confound our ability to evaluate the impact of paternal age upon fertilis-
ing ability. For example, maternal age, and a reduction in the frequency of intercourse with advancing age38,44. In 
fact, previous studies have failed to identify an association between male age and fertilisation outcomes following 
in vitro fertilisation (IVF), even when donated oocytes were used, and therefore, any maternal effect had been 
removed45–47. In addition, the fact that Spandofer et al.48 failed to detect any significant effect of male age upon 
fertilisation outcomes following ICSI, is consistent with our present results, since proportions of sperm exhibit-
ing PLCζ are known to be positively correlated with fertilisation rates28. Furthermore, confounding factors and 
covariates that are associated with age, such as vascular disease, obesity and factors related to lifestyle, may also 
mask the actual contribution of advancing age to the observed decline in sperm quality49–52.
Since the contribution of sperm to events occurring post-fertilisation is not restricted to PLCζ , the findings 
reported herein do not exclude the possibility that advancing male age could influence other important sperm 
factors. For example, sperm chromatin integrity, which has been linked to total fertilisation failure and miscar-
riage, is related to male age12,53–55.
In conclusion, the present study reports, for the first time, that the proportions, total levels and localisation 
patterns of PLCζ in human ejaculated sperm are not associated with male age. Consequently, while ageing is 
related to a clear reduction in sperm quality, it appears that the aging process does not affect all sperm pro-
teins, but rather acts upon specific parameters. Therefore, patients with reduced sperm quality due to age may 
be advised to use IVF/ICSI, since advancing male age is unlikely to cause problems in terms of the sperm’s fun-
damental ability to activate an oocyte and initiate the process of embryogenesis. Of course, this does not exclude 
that these processes may be influenced by the oocyte quality, and in particular the viability of oocyte proteins that 
might interact with PLCζ during gamete fusion.
Methods
Ethics. Males were recruited from the Oxford Fertility Unit (OFU; Oxford, UK) and from the Assisted 
Conception Unit (ACU; Ninewells Hospital, Dundee, UK) with approval from the National Research Ethics 
Service (South Central Oxford Committee C; Reference number: 10/H0606/65) and the East of Scotland Research 
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Ethics Service (EoSRES) (REC 1; Reference number: 13/ES/0091), respectively. Informed consent was obtained 
from all subjects involved in this study and all methods described in this section were carried out in accordance 
with the guidelines approved by the two Ethical Committees.
Sperm samples. Semen samples were provided following at least three days of abstinence. A total of 71 males 
were recruited into this study, ranging from 22 to 54 years of age (age, mean ± standard error of the mean, SEM: 
36.4 ± 0.7). All males were classified into either a fertile control group or an infertile patient group, as described by 
Yelumalai et al.28. The control group (n = 44; age, mean ± SEM: 35.8 ± 1.0) included (i) men with normal semen 
analysis parameters that were able to successfully fertilise an oocyte following assisted reproductive technology 
(ART), (ii) men with no history of infertility or oocyte activation deficiency, and (iii) men who had previously 
fathered children via natural conception. These clinical data were provided by the respective clinical uit provid-
ing the sample. All other samples were classified as infertile patients (n = 27; age, mean ± SEM: 37.4 ± 1.1 years) 
based upon sperm quality analysis, including total motile count, the proportion of sperm exhibiting progressive 
motility, sperm concentration (sperm·mL−1), and morphological abnormalities (e.g. sperm presenting pin-shaped 
or round heads). A history of total fertilisation failure following IVF and/or ICSI was also used as a criterion to 
classify samples into the infertile patient group28.
Preparation of sperm samples. Semen volume, pH, viscosity, sperm motility and sperm concentration 
were evaluated upon arrival in our laboratory, and were then subjected to density gradient washing (DGW) 
using PureSperm™ (PureSperm™ 40/80, Nidacon International AB, Gothenburg, Sweden), as described pre-
viously56. In brief, 2 mL of 80% PureSperm medium was layered onto the bottom of a 15 mL tube and overlaid 
with 2 mL of 40% PureSperm medium. Subsequently, 1.5 mL of liquefied semen sample was layered on top of 
the 40% PureSperm medium and samples centrifuged at 300× g (room temperature) for 20 min. Following the 
centrifugation step, most of the supernatant was discarded and approximately 0.5 mL of pellet remained at the 
bottom of the tube. This pellet was then transferred to a clean 15-mL tube containing 5 mL of PureSperm™ Wash 
medium (Nidacon International AB). This mixture was subsequently centrifuged at 500 × g (room temperature) 
for 10 min. The pellet was resuspended in 1 mL of PBS to evaluate sperm motility and 200 μ L was used for PLCζ 
analysis. This latter aliquot was centrifuged at 800 × g (room temperature) for three min and the supernatant dis-
carded without disturbing the remaining pellet. This pellet was resuspended with 100 μ L 4% paraformaldehyde 
(Sigma-Aldrich; Gillingham, Dorset, UK) and incubated at room temperature for 10 min in order to fix sperm 
cells. Following a final centrifugation step, and removal of paraformaldehyde, the sperm pellet was re-suspended 
and stored in 200 μ L PBS at 4 °C to await immunofluorescent analyses.
Evaluation of sperm quality. Sperm concentration and motility were assessed before and after DGW, as 
described in ref. 28, and according to WHO guidelines57. For the evaluation of sperm concentration, samples 
were diluted with sterile water (at a ratio of 1/20) and counted using a Neubauer chamber (Paul Marienfeld 
GmbH & Co. KG; Lauda-Königshofen, Germany). Two separate counts per sample were carried out.
Sperm motility was also evaluated in two independent replicates, in accordance with the latest WHO guide-
lines57. This analysis was performed taking into account the proportion of sperm exhibiting progressive sperm 
motility and the motile count, which represented the number of sperm exhibiting progressive motility.
Purification and specificity of the PLCζ antibody. Anti-human PLCζ antibody was synthesised by 
Cova-Lab (Cambridge, UK) against two immunogenic peptides identified in the human PLCζ amino acid 
sequence (C-RESKSYFNPSNIKE-coNH2 and C-ETHERKGSDKRGDN; Accession Number: AF532185). Before 
use, the crude antibody was purified with a SulfoLink Kit (Pierce Biotechnology, Rockford, USA), and the two 
original immunogenic peptides. Specificity of the PLCζ antibody was confirmed by competitive pre-incubation 
studies with excess peptides (data not shown), following the procedure described in ref. 29. The PLCζ antibody 
was proven to be specific since no immunostaining was observed when samples were incubated with antibody 
in the presence of blocking peptides. It is worth noting that the same antibody has been used in several other 
studies arising from this laboratory, and others, and has provided a consistent pattern of immunostaining 
throughout23,25,28,29,36,56.
Immunofluorescent detection of PLCζ. Sperm samples were immunostained for PLCζ using the proto-
col described by Grasa et al.29. First, a 100-μ L drop of fixed sperm was placed onto a slide pre-coated with 0.01% 
Poly-L-Lysine and permeabilised with 0.5% Triton X-100 in PBS (Sigma Aldrich) overnight. Slides were subse-
quently incubated with 3% bovine serum albumin (BSA, Sigma-Aldrich) at room temperature for one hour, and 
then with 100 μ L of anti-PLCζ antibody (25 μ g·mL−1; Cova-Lab, UK) diluted in 0.05% BSA at 4 °C and overnight. 
After this step, samples were washed three times with PBS and then incubated with 5 μ g·mL−1 of a secondary 
goat anti-rabbit antibody conjugated with Alexa Fluor 488 (Invitrogen, Paisley, UK) at room temperature for 
1 hour. After re-washing the slides with PBS a total of three times, 3 μ L of Vectashield H-1200 mounting medium 
containing 4′ -6′ -Diamidini-2-phenylindole (DAPI) (Vector, UK) was added onto the top of the sample prior to 
covering with 20 mm × 20 mm glass cover slips.
Evaluation of samples was performed under a fluorescence microscope (Eclipse 80i, Nikon UK Ltd., Kingston 
upon Thames, UK) at 400× magnification. Since the excitation wavelength for the secondary antibody was 
488 nm, a fluorescein isothiocyanate filter (FITC; Excitation filter: 465–495 nm; Dichroic Mirror: 505 nm: Barrier 
Filter: 515–550 nm) was used. All images were acquired with a Nikon DS-Ri1 camera (Nikon UK) at an exposure 
time of 400 ms. Illumination intensity and camera settings, such as quality (16-bit), resolution (1280 × 1024), 
and colour (high contrast), were set and standardised to ensure that they were the same for all images, following 
previously described protocols28,36. Prior to any evaluation, bright field images were used to select sperm heads 
for analyses and only those sperm that presented the head attached to the tail, and did not overlap with other 
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sperm, were selected. Fluorescent illumination was then used to outline the sperm heads through the region of 
interest manager (ROI) tool from ImageJ software (Version 1.46a; National Institutes of Health, Bethesda, MD, 
USA). For each slide, separate fields were randomly captured to image 100 sperm per sample. Mean PLCζ levels 
per sperm cell (arbitrary units) were quantified using Image J software. This mean value was derived from both 
sperm exhibiting PLCζ -staining and those that were devoid of staining. In addition, the proportion of sperm 
exhibiting PLCζ (in any localisation pattern), as well as the PLCζ localisation profile in each sperm cell, were 
evaluated following the procedure described by Grasa et al.29. Thus, PLCζ expression was assessed in each of the 
following eight localities: acrosomal (A); post-acrosomal (PA); equatorial (E); acrosomal and post-acrosomal 
(A + PA); acrosomal and equatorial (A + E); post-acrosomal and equatorial (PA + E); acrosomal, post-acrosomal 
and equatorial (A + PA + E); or ‘none’ indicating sperm totally devoid of PLCζ .
Statistical analyses. Data were managed using Microsoft Excel 2010 (Microsoft Corp., Redmond, 
Washington, USA) and IBM SPSS 21.0 for Windows; IBM Corp., Chicago, Illinois, USA) and the two graphs were 
prepared with Origin Pro 8.0 software (OriginLab Corp., Northampton, Massachusetts, USA).
Three different statistical approaches were taken after first checking the data for normality (Shapiro-Wilk test) 
and homogeneity of variance (homoscedasticity; Levene test). Since some of the data (x) in proportions did not 
fit with parametric assumptions, they were transformed using arcsine root transformation (arcsin √ x) and, when 
this transformation did not correct data normality and variance homogeneity, alternative non-parametric tests 
were used. Data for sperm motile counts were log-transformed prior to analysis. [log (x)].
The first statistical approach considered male age as a categorical factor. Thus, the effects of age and group 
(fertile controls and infertile patients) on proportions, total levels and localisation patterns of PLCζ , total motile 
count and the proportion of progressive motile sperm, were evaluated by two-way analysis of variance (ANOVA) 
followed by a post-hoc t-test with Bonferroni adjustment for pair-wise comparisons (the two factors used were 
the (i) age and (ii) the control/patient grouping). Since data for total proportions of sperm exhibiting PLCζ , and 
proportions of sperm with PLCζ localisation in E, A + PA and A + E did not match parametric assumptions, even 
after transformation, a two-way, non-parametric ANOVA for ranked data (Scheirer-Ray-Hare approach) was 
performed58. This approach is an extension of the Kruskal-Wallis test for two or more factors and calculates P 
values both for factors and their interaction by calculating an ‘H’ statistic. This H statistic results from dividing the 
sum of squares of a given factor (SS) by the mean squares (MS) and is then tested as a chi-square variable using 
the degrees of freedom pertaining to each factor (SS). The Mann-Whitney test was used to compare controls and 
patients regardless of age grouping, and to compare the two age groups regardless of whether data came from 
controls or patients.
The second approach considered male age as a continuous variable. In this case, correlation coefficients were 
calculated between male age, PLCζ parameters, motile count and the proportion of progressive motile sperm. 
These correlations were calculated with and without separating the statistical groups between controls and 
patients. Pearson correlations were used for these variables that required, or did not require, transformation, 
matched with parametric assumptions. In all other cases, Spearman correlations were carried out.
In the third approach, cases were first clustered via two-step cluster analysis using proportions, levels and 
localisation patterns as continuous variables. The log-likelihood was utilised as a measure for distance and the 
clustering was performed following Schwarz’s Bayesian Criterion (BIC). Descriptive statistics were calculated 
for the resulting clusters. The next step consisted of conducting logistic regression analyses using the number of 
clusters as the dependent variable and male age and grouping (controls vs. patients) as covariates. The method 
used was a forward stepwise protocol based on the likelihood ratio to determine the statistical significance of the 
factors as well as the order of importance. The probability-to-enter a variable into the model was 0.05 and the 
probability-to-remove was 0.10.
In all statistical tests, the significance level (two-tailed) was set at P ≤ 0.05. Data are expressed as mean ± stand-
ard error of the mean (SEM).
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